MONOCLONAL ANTI-CEA ANTIBODIES IN THE DISCRIMINATION BETWEEN PRIMARY PULMONARY ADENOCARCINOMA AND COLON-CARCINOMA METASTATIC TO THE LUNG

被引:0
|
作者
GHONEIM, AHA
BRISSON, ML
FUKS, A
MOBASHER, AAMT
KREISMAN, H
机构
[1] SIR MORTIMER B DAVIS JEWISH HOSP,DIV PULM,3775 COTE STE CATHERINE RD,MONTREAL H3T 1E2,QUEBEC,CANADA
[2] SIR MORTIMER B DAVIS JEWISH HOSP,DEPT MED,DIV PULM,MONTREAL H3T 1E2,QUEBEC,CANADA
[3] SIR MORTIMER B DAVIS JEWISH HOSP,DEPT PATHOL,DIV PULM,MONTREAL H3T 1E2,QUEBEC,CANADA
[4] MCGILL UNIV,MCGILL CANC CTR,MONTREAL H3A 2T5,QUEBEC,CANADA
[5] ZAGAZIG UNIV,FAC MED,DEPT PULM,ZAGAZIG,EGYPT
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
引用
收藏
页码:613 / 618
页数:6
相关论文
共 50 条
  • [21] BINDING OF 5 MONOCLONAL ANTI-CEA ANTIBODIES WITH DIFFERENT EPITOPE SPECIFICITIES TO VARIOUS CARCINOMA TISSUES
    WAGENER, C
    PETZOLD, P
    KOHLER, W
    TOTOVIC, V
    INTERNATIONAL JOURNAL OF CANCER, 1984, 33 (04) : 469 - 475
  • [22] COMPARATIVE IMAGING AND BIODISTRIBUTION STUDIES WITH AN ANTI-CEA MONOCLONAL-ANTIBODY AND ITS F(AB)2 AND FAB FRAGMENTS IN MICE WITH COLON-CARCINOMA XENOGRAFTS
    ANDREW, SM
    PIMM, MV
    PERKINS, AC
    BALDWIN, RW
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1986, 12 (04): : 168 - 175
  • [23] RADIOIMMUNOTHERAPY OF HUMAN-COLON CARCINOMA BY I-131-LABELED MONOCLONAL ANTI-CEA ANTIBODIES IN A NUDE-MOUSE MODEL
    BUCHEGGER, F
    VACCA, A
    CARREL, S
    SCHREYER, M
    MACH, JP
    INTERNATIONAL JOURNAL OF CANCER, 1988, 41 (01) : 127 - 134
  • [24] IMMUNOHISTOLOGIC CHARACTERIZATION OF GOLD TYPES-1-5 ANTI-CEA MONOCLONAL-ANTIBODIES IN COLON CANCER
    PAXTON, R
    BATTIFORA, JMEH
    METHA, P
    SHIVELY, J
    LABORATORY INVESTIGATION, 1992, 66 (01) : A46 - A46
  • [25] THE CLINICAL UTILITY OF RADIOLABELED GOAT AND PRIMATE ANTI-CEA SERA IN THE LOCALIZATION OF PRIMARY AND METASTATIC CARCINOMA
    SILVA, JS
    COX, CE
    SULLIVAN, DS
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 239 - 239
  • [26] DETECTION OF OCCULT METASTATIC ADENOCARCINOMA IN PATIENTS WITH RISING SERUM CEA BY 111-IN LABELED MONOCLONAL ANTI-CEA ZCE-025
    PATT, Y
    LAMKI, L
    JESSUP, J
    LEVIN, B
    AJANI, J
    HALVERSON, C
    SCHWEIGHARDT, S
    SHANKEN, J
    MURRAY, L
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 425 - 425
  • [27] IMAGING OF HUMAN-COLON CARCINOMA WITH IN-111 LABELED ANTI-CEA MONOCLONAL ANTI-BODIES (INDACEA)
    BEATTY, JD
    PHILBEN, VJ
    JAKOWATZ, JG
    WILLIAMS, LE
    PAXTON, RJ
    SHIVELY, JE
    BEATTY, BG
    VLAHOS, WG
    WERNER, JL
    SHEIBANI, K
    KEMENY, MM
    KOKAL, WA
    RIIHIMAKI, DU
    TERZ, JJ
    TUMOUR BIOLOGY, 1985, 6 (04): : 357 - 357
  • [28] CYTOKERATIN-7 AND CYTOKERATIN-20 AND CEA IN THE DIFFERENTIAL-DIAGNOSIS BETWEEN PRIMARY OVARIAN AND METASTATIC COLON-CARCINOMA
    BEREZOWSKI, K
    STASTNY, JF
    KORNSTEIN, MJ
    LABORATORY INVESTIGATION, 1995, 72 (01) : A86 - A86
  • [29] EVALUATION OF CEA EXPRESSION IN PRIMARY AND METASTATIC COLON CANCER USING A PANEL OF 3 MONOCLONAL-ANTIBODIES
    TUTTLE, SE
    PORTER, D
    BUCCI, DM
    PRIMUS, J
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1987, 87 (03) : 417 - 417
  • [30] IMPROVED DETECTION OF COLON-CARCINOMA BY USING TOMOSCINTIGRAPHY AND I-123 LABELED F(AB')2 FRAGMENTS OF ANTI-CEA MCABS
    MACH, JP
    BUCHEGGER, F
    GROB, JP
    VONFLIEDNER, V
    BISCHOFDELALOYE, A
    DELALOYE, B
    BRITISH JOURNAL OF CANCER, 1984, 50 (04) : 551 - 551